Literature DB >> 15933742

No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome.

M Ittah1, J-E Gottenberg, A Proust, E Hachulla, X Puechal, P Loiseau, X Mariette, C Miceli-Richard.   

Abstract

One-third of first-degree relatives of patients with primary Sjögren's syndrome (pSS) suffer from other autoimmune diseases, including type I diabetes, systemic lupus erythematosus and autoimmune thyroiditis. Recently, 1858 C/T polymorphism of PTPN22 gene was reported to predispose to these autoimmune diseases. We decided to investigate whether PTPN22 gene polymorphism was also involved in the genetic predisposition to pSS in a case-control study, including 183 patients with pSS and 172 healthy controls. No significant differences in allele (T allele frequency: 7.7% in patients with pSS vs 7.8% in controls, P=0.9) and genotype frequencies of PTPN22 polymorphism were detected between patients with pSS and controls. PTPN 22 gene polymorphism was not associated with a specific pattern of autoantibody secretion either. Thus, 1858 C/T polymorphism of PTPN22 gene is not involved in genetic predisposition to pSS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933742     DOI: 10.1038/sj.gene.6364229

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  10 in total

Review 1.  Horizons in Sjögren's syndrome genetics.

Authors:  Pamela H Williams; Beth L Cobb; Bahram Namjou; R Hal Scofield; Amr H Sawalha; John B Harley
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

2.  Association of PTPN22 gene polymorphism and systemic lupus erythematosus in a cohort of Egyptian patients: impact on clinical and laboratory results.

Authors:  Pacint Moez; Eiman Soliman
Journal:  Rheumatol Int       Date:  2011-08-05       Impact factor: 2.631

3.  Defective Early B Cell Tolerance Checkpoints in Sjögren's Syndrome Patients.

Authors:  Salomé Glauzy; Joel Sng; Jason M Bannock; Jacques-Eric Gottenberg; Anne-Sophie Korganow; Patrice Cacoub; David Saadoun; Eric Meffre
Journal:  Arthritis Rheumatol       Date:  2017-10-12       Impact factor: 10.995

Review 4.  Genes and Sjögren's syndrome.

Authors:  Beth L Cobb; Christopher J Lessard; John B Harley; Kathy L Moser
Journal:  Rheum Dis Clin North Am       Date:  2008-11       Impact factor: 2.670

Review 5.  PTPN22: its role in SLE and autoimmunity.

Authors:  Sharon A Chung; Lindsey A Criswell
Journal:  Autoimmunity       Date:  2007-12       Impact factor: 2.815

6.  Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population.

Authors:  J Wipff; Y Allanore; A Kahan; O Meyer; L Mouthon; L Guillevin; C Pierlot; E Glikmans; T Bardin; C Boileau; F Cornélis; P Dieudé
Journal:  Ann Rheum Dis       Date:  2006-02-07       Impact factor: 19.103

7.  Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele.

Authors:  Philippe Dieudé; Sophie Garnier; Laëtitia Michou; Elisabeth Petit-Teixeira; Elodie Glikmans; Céline Pierlot; Sandra Lasbleiz; Thomas Bardin; Bernard Prum; François Cornélis
Journal:  Arthritis Res Ther       Date:  2005-08-25       Impact factor: 5.156

Review 8.  Coherent somatic mutation in autoimmune disease.

Authors:  Kenneth Andrew Ross
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

9.  Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients.

Authors:  Philipp S Fuchs; Jonas Lötscher; Caroline M Berkemeier; Julia R Hirsiger; Adhideb Ghosh; Quan-Zhen Li; Nikolaus Deigendesch; Emanuel Christ; Alexander A Navarini; Mike Recher; Thomas Daikeler; Ingmar A F M Heijnen; Christoph T Berger
Journal:  Front Immunol       Date:  2020-12-21       Impact factor: 7.561

Review 10.  Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.

Authors:  Adrianos Nezos; Clio P Mavragani
Journal:  J Immunol Res       Date:  2015-10-15       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.